Pascal and Francis Bibliographic Databases


Search results

Your search


Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 740

  • Page / 30

Selection :

  • and

Identification of Novel Biphenyl Carboxylic Acid Derivatives as Novel Antiresorptive Agents that Do Not Impair Parathyroid Hormone-Induced Bone FormationIDRIS, Aymen I; GREIG, Iain R; BASSONGA-LANDAO, Euphemie et al.Endocrinology (Philadelphia). 2009, Vol 150, Num 1, pp 5-13, issn 0013-7227, 9 p.Article

Risedronate on Two Consecutive Days per MonthFRAMPTON, James E.Drugs & aging. 2009, Vol 26, Num 4, pp 355-362, issn 1170-229X, 8 p.Article

Are Cathepsin K Inhibitors Just Another Class of Anti-Resorptives?CHAMBERS, T. J; TOBIAS, J. H.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 11, pp 4329-4331, issn 0021-972X, 3 p.Article

Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of boneGOUIN, Francois; ROCHWERGER, Alexandre R; DI MARCO, Antonio et al.European journal of cancer (1990). 2014, Vol 50, Num 14, pp 2425-2431, issn 0959-8049, 7 p.Article

EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate CancerHEIDENREICH, Axel; BASTIAN, Patrick J; MOTTET, Nicolas et al.European urology. 2014, Vol 65, Num 2, pp 467-479, issn 0302-2838, 13 p.Article

Modelling the Cost Effectiveness of Interventions for Osteoporosis: Issues to ConsiderSTEVENSON, Matt D; SELBY, Peter L.PharmacoEconomics (Auckland). 2014, Vol 32, Num 8, pp 735-743, issn 1170-7690, 9 p.Article

Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In VivoOTTEWELL, Penelope D; NING WANG; BROWN, Hannah K et al.Clinical cancer research (Print). 2014, Vol 20, Num 11, pp 2922-2932, issn 1078-0432, 11 p.Article

Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblastsZAFAR, S; COATES, D. E; CULLINAN, M. P et al.Journal of oral pathology & medicine. 2014, Vol 43, Num 9, pp 711-721, issn 0904-2512, 11 p.Article

Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?COSMAN, Felicia; CAULEY, Jane A; EASTELL, Richard et al.The Journal of clinical endocrinology and metabolism. 2014, Vol 99, Num 12, pp 4546-4554, issn 0021-972X, 9 p.Article

A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) StudyKLOTZ, Laurence H; MCNEILL, Irene Y; KEBABDJIAN, Marlene et al.European urology. 2013, Vol 63, Num 5, pp 927-935, issn 0302-2838, 9 p.Article

Denosumab for treatment of bone metastases secondary to solid tumours: Systematic review and network meta-analysisFORD, John A; JONES, Rob; ELDERS, Andrew et al.European journal of cancer (1990). 2013, Vol 49, Num 2, pp 416-430, issn 0959-8049, 15 p.Article

The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fractureANAGNOSTIS, Panagiotis; VYZANTIADIS, Timoleon-Achilleas; CHARIZOPOULOU, Maria et al.Thrombosis and haemostasis. 2013, Vol 110, Num 2, pp 257-263, issn 0340-6245, 7 p.Article

Water enhanced synthesis of gem-bisphosphonates via Rh(ı) mediated 1,4-conjugate addition of aryl boronic acids to vinylidenebisphosphonate esterstBIANCHINI, Giulio; SCARSO, Alessandro; CHIMINAZZO, Andrea et al.Green chemistry (Print). 2013, Vol 15, Num 3, pp 656-662, issn 1463-9262, 7 p.Article

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsCOLEMAN, R; DE BOER, R; FRASSOLDATI, A et al.Annals of oncology. 2013, Vol 24, Num 2, pp 398-405, issn 0923-7534, 8 p.Article

Traitement à domicile par l'acide zolédronique chez des patients atteints de tumeurs solides: observance et satisfaction du patient et de l'infirmier = Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient-nurse satisfactionLEBRET, Thierry; MOUYSSET, Jean-Loup; LORTHOLARY, Alain et al.Bulletin du cancer. 2013, Vol 100, Num 3, pp 247-257, issn 0007-4551, 11 p.Article

Age effect on bone mineral density changes in breast cancer patients receiving anastrozole: results from the ARBI prospective clinical trialMARKOPOULOS, Christos; TZORACOLEFTHERAKIS, Evagelos; KOUKOURAS, Dimitrios et al.Journal of cancer research and clinical oncology. 2012, Vol 138, Num 9, pp 1569-1577, issn 0171-5216, 9 p.Article

Bone Micromechanical Properties Are Compromised During Long-Term Alendronate Therapy Independently of MineralizationBALA, Yohann; DEPALLE, Baptiste; FARLAY, Delphine et al.Journal of bone and mineral research (Print). 2012, Vol 27, Num 4, pp 825-834, issn 0884-0431, 10 p.Article

Bone metastasis targeting: A novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with DocetaxelRAMANLAL CHAUDHARI, Kiran; KUMAR, Abhinesh; MEGRAJ KHANDELWAL, Vinoth Kumar et al.Journal of controlled release. 2012, Vol 158, Num 3, pp 470-478, issn 0168-3659, 9 p.Article

Clinical Efficacy of 1 % Alendronate Gel in Adjunct to Mechanotherapy in the Treatment of Aggressive Periodontitis: A Randomized Controlled Clinical TrialSHARMA, Anuj; PRADEEP, A. R.Journal of periodontology (1970). 2012, Vol 83, Num 1, pp 19-26, issn 0022-3492, 8 p.Article

Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds: histomorphometric, receptor activator of nuclear factor-kB ligand, osteopro- tegerin, von Willebrand factor, and caspase-3 evaluationVASCONCELOS, Ana C. U; BERTI-COUTO, Soraya A; AZAMBUJA, Alan A et al.Journal of oral pathology & medicine. 2012, Vol 41, Num 9, pp 702-712, issn 0904-2512, 11 p.Article

Cost-Effectiveness of Denosumab Versus Zoledronic Acid in the Management of Skeletal Metastases Secondary to Breast CancerSNEDECOR, Sonya J; CARTER, John A; KAURA, Satyin et al.Clinical therapeutics. 2012, Vol 34, Num 6, pp 1334-1349, issn 0149-2918, 16 p.Article

Cytostatic Activity of a 5-Fluoro-2'-deoxyuridine―Alendronate Conjugate against Gastric Adenocarcinoma and Non-malignant Intestinal and Fibroblast Cell LinesWEINREICH, Jurgen; SCHOTT, Timm C; KÖNIGSRAINER, Ingmar et al.Anticancer research. 2012, Vol 32, Num 10, pp 4299-4305, issn 0250-7005, 7 p.Article

Effect of Risedronate on Bone in Renal Transplant RecipientsCOCO, Maria; PULLMAN, James; COHEN, Hillel W et al.Journal of the American Society of Nephrology. 2012, Vol 23, Num 8, pp 1426-1437, issn 1046-6673, 12 p.Article

Effects of Alendronate and Risedronate on Bone Material Properties in Actively Forming Trabecular Bone SurfacesHOFSTETTER, Birgit; GAMSJAEGER, Sonja; PHIPPS, Roger J et al.Journal of bone and mineral research (Print). 2012, Vol 27, Num 5, pp 995-1003, issn 0884-0431, 9 p.Article

Fracture Risk and Zoledronic Acid Therapy in Men with OsteoporosisBOONEN, Steven; REGINSTER, Jean-Yves; ERIKSEN, Erik et al.The New England journal of medicine. 2012, Vol 367, Num 18, pp 1714-1723, issn 0028-4793, 10 p.Article

  • Page / 30